General MedicationsORALGeneric

AGENERASE

AMPRENAVIR

Standard Dose

15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview AGENERASE is listed in Drugs@FDA under application 021039 (NDA).

Marketing status: Discontinued Active ingredient AMPRENAVIR Form and strength SOLUTION;ORAL - 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2005-11-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview AGENERASE is listed in Drugs@FDA under application 021039 (NDA). Marketing status: Discontinued Active ingredient AMPRENAVIR Form and strength SOLUTION;ORAL - 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2005-11-04 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.